Clinical responses to tumor necrosis factor alpha antagonists do not show a bimodal distribution: data from the Stockholm tumor necrosis factor alpha followup registry.

Clinical responses to tumor necrosis factor alpha antagonists do not show a bimodal distribution: data from the Stockholm tumor necrosis factor alpha followup registry.

Item
http://www.wikidata.org/entity/Q30801601
The gene expression profile in the synovium as a predictor of the clinical response to infliximab treatment in rheumatoid arthritisGreen tea extract inhibits chemokine production, but up-regulates chemokine receptor expression, in rheumatoid arthritis synovial fibroblasts and rat adjuvant-induced arthritisLow-dose glucocorticoid therapy decreases risk for treatment-limiting infusion reaction to infliximab in patients with rheumatoid arthritis.Thresholds in disease activity for switching biologics in rheumatoid arthritis patients: experience from a large U.S. cohort.A personalized medicine approach to biologic treatment of rheumatoid arthritis: a preliminary treatment algorithm.The clinical response to infliximab in rheumatoid arthritis is in part dependent on pretreatment tumour necrosis factor alpha expression in the synovium.Infliximab dosage and infusion frequency in clinical practice: experiences in the Stockholm biologics registry STURE.Blood autoantibody and cytokine profiles predict response to anti-tumor necrosis factor therapy in rheumatoid arthritis.Switching between anti-tumour necrosis factors: trying to get a handle on a complex issueLow remission rates but long drug survival in rheumatoid arthritis patients treated with infliximab or etanercept: results from the nationwide Danish DANBIO database.APL-1, an altered peptide ligand derived from heat-shock protein, alone or combined with methotrexate attenuates murine collagen-induced arthritis.Adalimumab (Humira®) restores clinical response in patients with secondary loss of efficacy from infliximab (Remicade®) or etanercept (Enbrel®): results from the STURE registry at Karolinska University Hospital
P2860

Clinical responses to tumor necrosis factor alpha antagonists do not show a bimodal distribution: data from the Stockholm tumor necrosis factor alpha followup registry.

Item
http://www.wikidata.org/entity/Q30801601
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Clinical responses to tumor ne ...... actor alpha followup registry.
@ast
Clinical responses to tumor ne ...... actor alpha followup registry.
@en
type
label
Clinical responses to tumor ne ...... actor alpha followup registry.
@ast
Clinical responses to tumor ne ...... actor alpha followup registry.
@en
prefLabel
Clinical responses to tumor ne ...... actor alpha followup registry.
@ast
Clinical responses to tumor ne ...... actor alpha followup registry.
@en
P1433
P1476
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P356
P1433
P1476
Clinical responses to tumor ne ...... actor alpha followup registry.
@en
P304
P31
P356
P433
P478
P50
P577
P5875
P698